Strong TCR ligation without costimulation causes rapid onset of Fas- dependent apoptosis of naive murine CD4+ T cells

Journal of Immunology

Volumn 163, Issue 4, 1999, Pages 1817-1826

  Kishimoto, Hidehiro ^a   Sprent, Jonathan ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; FLOW CYTOMETRY; HELPER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; FAS LIGAND PROTEIN; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTRACELLULAR FLUID; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; T-LYMPHOCYTE SUBSETS; TIME FACTORS;

EID: 0033566826     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Green, D. R., and D. W. Scott. 1994. Activation-induced apoptosis in lymphocytes. Curr. Opin. Immunol. 6:476.
2. Crispe, I. N. 1994. Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity 1:347.
3. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
4. Sprent, J., and S. R. Webb. 1995. Intrathymic and extrathymic clonal deletion of T cells. Curr. Opin. Immunol. 7:196.
5. Theofilopoulos, A. N. 1995. The basis of autoimmunity. I. Mechanisms of aberrant self-recognition. Immunol. Today 16:90.
6. Singer, G. G., and A. K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
7. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
8. Dhein, J., H. Walczak, C. Baumler, K.-M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1(Fas/CD95). Nature 373:438.
9. Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
10. Mogil, R. J., L. Radvanyi, R. Gonzalez-Quintial, R. Miller, G. Mills, A. N. Theofilopoulos, and D. R. Green. 1995. Fas(CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int. Immunol. 7:1451.
11. Van Parijs, L., A. Ibraghimov, and A. Abbas. 1996. Role of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
12. Lenardo, M. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858.
13. Rafaeli, Y., L. Van Parijs, C. London, J. Tschopp, and A. Abbas. 1998. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8:615.
14. Boise, L., P. Noel, and C. Thompson. 1995. CD28 and apoptosis. Curr. Opin. Immunol. 7:620.
15. Noel, P., L. Boise, J. Green, and C. Thompson. 1996. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157:636.
16. Boise, L., A. Minn, P. Noel, C. June, M. Accavitti, T. Lindsten, and C. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3:87.
17. Radvanyi, L. G., Y. Shi, H. Vaziri, A. Sharma, R. Dhala, G. B. Mills, and R. G. Miller. 1996. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J. Immunol. 156:1788.
18. Kishimoto, H., and J. Sprent. 1997. Negative selection in the thymus includes semimature T cells. J. Exp. Med. 185:263.
19. Vella, A., T. Teague, J. Ihle, J. Kappler, and P. Marrack. 1997. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: STAT6 is probably not required for the effect of IL-4. J. Exp. Med. 186:325.
20. + T cells by semiprofessional antigen-presenting cells in vivo. J. Exp. Med. 176:1291.
21. Lane, P., W. Gerhard, S. Hubele, A. Lanzavecchia, and F. McConnell. 1993. Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human γ1. Immunology 80:56.
22. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin-2, 3, 4, or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97.
23. Rolink, A., A. Kudo, H. Karasuyama, Y. Kikuchi, and F. Melchers. 1991. Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo. EMBO J. 10:327.
24. Kishimoto, H., C. D. Surh, and J. Sprent. 1995. Upregulation of surface markers on dying thymocytes. J. Exp. Med. 181:649.
25. Kishimoto, H., Z. Cai, A. Brunmark, M. R. Jackson, P. A. Peterson, and J. Sprent. 1996. Differing roles for B7 and intercellular adhesion molecule-1 in the negative selection of thymocytes. J. Exp. Med. 184:531.
26. Van Seventer, G., Y. Shimizu, K. Horgan, and S. Shaw. 1990. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J. Immunol. 144:4579.
27. + T cells: ICAM-1 or B7-1 can costimulate naive CD4 T cell activation but both are required for optimam response. J. Immunol. 155:45.
28. + T cells. Proc. Natl. Acad. Sci. USA 93:14736.
29. Sperling, A., J. Green, R. Mosley, P. Smith, R. DiPaolo, J. Klein, J. Bluestone, and C. Thompson. 1995. CD43 is a murine T cell costimulatory receptor that functions independently of CD28. J. Exp. Med. 182:139.
30. + thymocytes by the anti-Fas antibody. J. Exp. Med. 181:485.
31. Dolbeare, F., H. Gratzner, M. Pallavicini, and J. Gray. 1983. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc. Natl. Acad. Sci. USA 80:5573.
32. Tough, D. F., and J. Sprent. 1994. Turnover of naive- and memory-phenotype T cells. J. Exp. Med. 179:1127.
33. Shevach, E. 1985. The effects of cyclosporin A on the immune system. Annu. Rev. Immunol. 3:397.
34. Waters, S., K. Holt, S. Ross, L. Syu, K. Guan, A. Saltiel, G. Koretzky, and J. Pessin. 1995. Desensitization of Ras activation by a feedback disassociation of the SOS-Grb2 complex. J. Biol. Chem. 270:20883.
35. Pang, L., T. Sawada, S. Decker, and A. Saltiel. 1995. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270:13585.
36. Lee, J., J. Laydon, P. McDonnell, T. Gallagher, S. Kumar, D. Green, D. McNulty, M. Blumenthal, J. Heys, S. Landvatter, et al. 1994. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739.
37. Cuenda, A., J. Rouse, Y. Doza, R. Meier, P. Cohen, T. Gallgher, P. Young, and J. Lee. 1995. SB203580 is a specific inhibitor of MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229.
38. Hu, S., C. Vicentz, J. Ni, R. Genz, and V. M. Dixit. 1997. I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1 and CD95-induced apoptosis. J. Biol. Chem. 272:17255.
39. Irmler, M., M. Tome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J. Bodmer, M. Schroter, K. Burns, C. Mattmann, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190.
40. Alderson, M. R., T. W. Tough, S. Braddy, T. Davis-Smith, E. Roux, K. Schooley, R. E. Miller, and D. H. Lynch. 1994. Regulation of apoptosis and T cell activation by Fas-specific mAb. Int. Immunol. 6:1799.
41. June, C. H., J. A. Bluestone, L. M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol. Today 15:321.
42. Uyttenhove, C., P. Coulie, and J. Van Snick. 1988. T cell growth and differentiation induced by interleukin HP1/6, the murine hybridoma/plasmacytoma growth factor. J. Exp. Med. 167:1417.
43. Lotz, M., F. Jirik, R. Kabouridis, C. Tsoukas, T. Hirano, T. Kishimoto, and D. Carson. 1988. B cell stimulationg factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J. Exp. Med 167:1253.
44. Teague, T., P. Marrack, J. Kappler, and A. Vella. 1997. IL-6 rescues resting mouse T cells from apoptosis. J. Immunol. 158:5791.
45. Harrington, E., M. Bennett, A. Fanidi, and G. Evan. 1994. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO. J. 13:3286.
46. Hueber, A.-O., M. Zornig, D. Lyon, T. Suda, S. Nagata, and G. Evan. 1997. Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 278:1305.
47. Van Antwerp, D., S. Martin, I. Verma, and D. Green. 1998. Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell. Biol. 8:107.
48. Johnson, N., A. Gardner, K. Diener, C. Lange-Carter, J. Gleavy, M. Jarpe, A. Minden, M. Karin, L. Zon, and G. Johnson. 1996. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J. Biol. Chem. 271:3229.
49. Amundadottir, L., and P. Leder. 1998. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes. Oncogene 16:737.
50. Vanier, L., and G. Prud'homme. 1992. Cyclosporin A markedly enhances superantigen-induced peripheral T cell deletion and inhibits anergy induction. J. Exp. Med. 176:37.
51. Kuschnaroff, L., D. Valckx, J. Goebels, O. Rutgeerts, H. Heremants, G. Froyent, and M. Waer. 1997. Effect of treatments with cyclosporin A and anti-interferon-γ antibodies on the mechanisms of immune tolerance in staphylococcal enterotoxin B primed mice. Scand. J. Immunol. 46:459.
52. Mittrucker, H., A. Shahinian, D. Bouchard, T. Kundig, and T. Mak. 1996. Induction of unresponsiveness and impaired T cell expansion by staphylococcal enterotoxin B in CD28-deficient mice. J. Exp. Med. 183:2481.
53. + T cells are hyperreactive to antigenic challenge in vitro. J. Exp. Med. 184:2141.